BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 22102731)

  • 1. Pillars article: A protein tyrosine kinase in the interferon α/β signaling pathway. Cell. 1992. 70: 313-322.
    Velazquez L; Fellous M; Stark GR; Pellegrini S
    J Immunol; 2011 Dec; 187(11):5479-88. PubMed ID: 22102731
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytokine signaling: birth of a pathway.
    O'Shea JJ; Gadina M; Kanno Y
    J Immunol; 2011 Dec; 187(11):5475-8. PubMed ID: 22102730
    [No Abstract]   [Full Text] [Related]  

  • 3. Interferon research BC (before cloning).
    Vilcek J
    Curr Top Microbiol Immunol; 2007; 316():9-22. PubMed ID: 17969441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of lipopolysaccharide-induced inducible nitric-oxide synthase expression through the nuclear factor-kappaB pathway and interferon-beta/tyrosine kinase 2/Janus tyrosine kinase 2-signal transducer and activator of transcription-1 signaling cascades by 2-naphthylethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (THI 53), a new synthetic isoquinoline alkaloid.
    Kim HJ; Tsoyi K; Heo JM; Kang YJ; Park MK; Lee YS; Lee JH; Seo HG; Yun-Choi HS; Chang KC
    J Pharmacol Exp Ther; 2007 Feb; 320(2):782-9. PubMed ID: 17108235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of hybrid type I interferons in cells lacking Tyk2: a common region of IFN-alpha 8 induces a response, but IFN-alpha2/8 hybrids can behave like IFN-beta.
    Platis D; Foster GR
    J Interferon Cytokine Res; 2003 Nov; 23(11):655-66. PubMed ID: 14651780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dual role for the kinase-like domain of the tyrosine kinase Tyk2 in interferon-alpha signaling.
    Yeh TC; Dondi E; Uze G; Pellegrini S
    Proc Natl Acad Sci U S A; 2000 Aug; 97(16):8991-6. PubMed ID: 10908660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha.
    Li S; Labrecque S; Gauzzi MC; Cuddihy AR; Wong AH; Pellegrini S; Matlashewski GJ; Koromilas AE
    Oncogene; 1999 Oct; 18(42):5727-37. PubMed ID: 10523853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Atlantic salmon protein tyrosine kinase Tyk2: molecular cloning, modulation of expression and function.
    Sobhkhez M; Hansen T; Iliev DB; Skjesol A; Jørgensen JB
    Dev Comp Immunol; 2013 Dec; 41(4):553-63. PubMed ID: 23872231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mutant form of p135tyk2, an interferon-alpha inducible tyrosine kinase, suppresses the transformed phenotype of Daudi cells.
    Davis E; Krishnan K; Yan H; Newcomb EW; Krolewski JJ
    Leukemia; 1996 Mar; 10(3):543-51. PubMed ID: 8642873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyk2 tyrosine kinase expression is required for the maintenance of mitochondrial respiration in primary pro-B lymphocytes.
    Potla R; Koeck T; Wegrzyn J; Cherukuri S; Shimoda K; Baker DP; Wolfman J; Planchon SM; Esposito C; Hoit B; Dulak J; Wolfman A; Stuehr D; Larner AC
    Mol Cell Biol; 2006 Nov; 26(22):8562-71. PubMed ID: 16982690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the interferon-gamma signal transduction pathway.
    Watling D; Guschin D; Müller M; Silvennoinen O; Witthuhn BA; Quelle FW; Rogers NC; Schindler C; Stark GR; Ihle JN
    Nature; 1993 Nov; 366(6451):166-70. PubMed ID: 7901766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyk2 is essential for IFN-alpha-induced gene expression in mast cells.
    Mori Y; Hirose K; Suzuki K; Nakajima H; Seto Y; Ikeda K; Shimoda K; Nakayama K; Saito Y; Iwamoto I
    Int Arch Allergy Immunol; 2004 Jun; 134 Suppl 1():25-9. PubMed ID: 15166480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Requirement of catalytically active Tyk2 and accessory signals for the induction of TRAIL mRNA by IFN-beta.
    Rani MR; Pandalai S; Shrock J; Almasan A; Ransohoff RM
    J Interferon Cytokine Res; 2007 Sep; 27(9):767-79. PubMed ID: 17892398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon beta-lb is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. 1993 [classical article].
    Paty DW; Li DK;
    Neurology; 2001 Dec; 57(12 Suppl 5):S10-5. PubMed ID: 11902589
    [No Abstract]   [Full Text] [Related]  

  • 15. Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock.
    Karaghiosoff M; Steinborn R; Kovarik P; Kriegshäuser G; Baccarini M; Donabauer B; Reichart U; Kolbe T; Bogdan C; Leanderson T; Levy D; Decker T; Müller M
    Nat Immunol; 2003 May; 4(5):471-7. PubMed ID: 12679810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A weak signal for strong responses: interferon-alpha/beta revisited.
    Taniguchi T; Takaoka A
    Nat Rev Mol Cell Biol; 2001 May; 2(5):378-86. PubMed ID: 11331912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon beta-lb is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. 1993 [classical article].
    IFNB Multiple Sclerosis Study Group
    Neurology; 2001 Dec; 57(12 Suppl 5):S3-9. PubMed ID: 11902592
    [No Abstract]   [Full Text] [Related]  

  • 18. TYK2, a Candidate Gene for Type 1 Diabetes, Modulates Apoptosis and the Innate Immune Response in Human Pancreatic β-Cells.
    Marroqui L; Dos Santos RS; Fløyel T; Grieco FA; Santin I; Op de Beeck A; Marselli L; Marchetti P; Pociot F; Eizirik DL
    Diabetes; 2015 Nov; 64(11):3808-17. PubMed ID: 26239055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Jak-STAT pathway stimulated by interferon alpha or interferon beta.
    Horvath CM
    Sci STKE; 2004 Nov; 2004(260):tr10. PubMed ID: 15561979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis. 1997.
    Rudick RA; Goodkin DE; Jacobs LD; Cookfair DL; Herndon RM; Richert JR; Salazar AM; Fischer JS; Granger CV; Simon JH; Alam JJ; Simonian NA; Campion MK; Bartoszak DM; Bourdette DN; Braiman J; Brownscheidle CM; Coats ME; Cohan SL; Dougherty DS; Kinkel RP; Mass MK; Munschauer FE; Priore RL; Pullicino PM; Scherokman BJ; Weistock-Guttman B; Whitham RH;
    Neurology; 2001 Dec; 57(12 Suppl 5):S25-30. PubMed ID: 11902591
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.